KYVERNA THERAPEUTICS INC (KYTX) Stock Analyst Earnings Estimates
NASDAQ:KYTX - Nasdaq - US5019761049 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.656M | 7.025M 24.20% | -100.00% | 1.418M | 24.276M 1,611.99% | 149.38M 515.34% | 466.19M 212.08% | 944.93M 102.69% | 1.581B 67.31% | ||||
| EBITDA YoY % growth | -25.76M | -28.333M -9.99% | -63.196M -114.23% | -145.973M -132.07% | -191.639M -36.04% | -227.645M -18.79% | -289.586M -27.21% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -26.346M | -29.384M -11.53% | -63.082M -112.38% | -144.88M -129.14% | -193.959M -35.64% | -233.333M -20.30% | -314.131M -34.63% | -394.74M -25.66% | -461.04M -16.80% | -197.88M 57.08% | N/A | N/A | |
| Operating Margin | -465.81% | -418.28% | N/A | N/A | N/A | N/A | -22,153.08% | -1,626.05% | -308.64% | -42.45% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -8.79 | -3.36 60.53% | -3.73 -7.35% | -3.21 13.84% | -3.64 -13.45% | -3.59 1.40% | -3.36 6.53% | -1.11 66.87% | 3.50 414.68% | 9.31 166.18% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.06 -58.84% | -0.93 -16.66% | -0.81 7.66% | -0.76 26.22% |
| Revenue Q2Q % growth | N/A | |||
| EBITDA Q2Q % growth | -47.94M -49.86% | -51M -37.10% | -54.06M -38.94% | N/A |
| EBIT Q2Q % growth | -48.046M -45.59% | -45.759M -18.03% | -45.818M -11.64% | -40.29M 15.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.03 8.04% | -1.14 | 0.11 | 9.30% |
| Q4 2024 Q2Q % growth | -0.88 96.72% | -0.85 | -0.03 | -2.95% |
| Q3 2024 Q2Q % growth | -0.80 | -0.80 | 0.00 | 0.51% |
| Q2 2024 Q2Q % growth | -0.67 | -0.71 | 0.04 | 5.89% |
| Q1 2024 Q2Q % growth | -1.12 | -0.86 | -0.26 | -30.72% |
| Q4 2023 Q2Q % growth | -26.86 | -3.29 | -23.57 | -716.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.11% | 5.88% | 6.12% |
| Revenue | N/A | N/A | N/A | N/A |